HOME >> BIOLOGY >> NEWS
JCI table of contents, 15 October, 2003

odium balance is believed to be a crucial mechanism that permits the excretion of water and electrolytes from the kidney into the urine to be finely balanced with dietary salt intake.

TITLE: Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load

AUTHOR CONTACT:
John N. Lorenz
University of Cincinnati School of Medicine, Cincinnati, Ohio, USA.
Phone: (513) 558-3097
Fax: (513) 558-5738
Email: john.lorenz@uc.edu

View the PDF of this article at: https://www.the-jci.org/press/18743.pdf

ACCOMPANYING COMMENTARY:
A novel role for uroguanylin in the regulation of sodium balance

AUTHOR CONTACT:
Leonard R. Forte
University of Missouri, Columbia, Missouri, USA.
Phone: (573) 814-6000
Fax: (573) 814-6551
E-mail: lrf@missouri.edu

View the PDF of this commentary at: https://www.the-jci.org/press/20057.pdf


Immunological tug of war between IL-12 and IL-23

Experimental autoimmune encephalomyelitis (EAE) is an animal model of human multiple sclerosis. Microglia and macrophages that reside within the central nervous system (CNS) are a source of the inflammatory cytokines IL-23 and IL-12. Until recently it was considered that IL-12 was a major mediator in the development of EAE, however within the last year it has been reported that IL-23 and not IL-12 is essential in the development of EAE. Burkhard Becher and colleagues from the University of Zurich, Switzerland, and Dartmouth College, New Hampshire, USA, now show that the p40 subunit, shared by both IL-12 and IL-23, plays a critical role in maintaining encephalitogenicity during the course of this disease. The authors d
'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
15-Oct-2003


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
3. JCI table of contents September 15, 2004
4. JCI table of contents: 1 September, 2004
5. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
6. JCI table of contents, 16 August, 2004
7. JCI table of contents, 2 August, 2004
8. When male fish hum, females swim in, thanks to hormones, adaptable hearing
9. JCI table of contents, 1 July 2004
10. Search and destroy protein turns tables on HIV
11. JCI table of contents, 15 June 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2016)... Minn. , Jan. 20, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... 2015. MedNet,s significant achievements are the result of the ... iMedNet eClinical , it,s comprehensive, easy-to-use ... --> --> Key MedNet growth achievements ...
(Date:1/18/2016)... 18, 2016  Extenua Inc., a pioneering developer ... use and access of ubiquitous on-premise and cloud ... American Cyber.  ... transformational C4ISR and Cyber initiatives in support of ... proven technology solutions," said Steve Visconti , ...
(Date:1/13/2016)... , January 13, 2016 ... has published a new market report titled - Biometric Sensors ... and Forecast, 2015 - 2023. According to the report, the global ... and is anticipated to reach US$1,625.8 mn by 2023, ... 2023. In terms of volume, the biometric sensors market ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... SAN FRANCISCO , February 5, 2016 ... AMBS), a biotechnology company focused on developing products ... it has requested Rare Pediatric Disease Designation (RPDD) from ... retinitis pigmentosa (RP) with MANF. MANF was previously granted ... December 2014. --> Amarantus BioScience Holdings, Inc. ...
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Sangamo BioSciences, ... genome editing, announced today that Edward Lanphier , ... update on the progress of Sangamo,s ZFP Therapeutic ® ... business strategy at 2:40 pm ET on Thursday, February ... Annual Global Healthcare Conference. The conference is being held ...
(Date:2/4/2016)... , Feb. 4, 2016  CytoSorbents Corporation ... leader commercializing its flagship CytoSorb® blood filter to ... patients around the world, announced that CEO Dr. ... at the Source Capital Group,s 2016 Disruptive Growth ... on the company.  Conference Presentation ...
(Date:2/4/2016)... -- Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property development ... property, today provided an update on the Company,s cases ... Texas and announcing that those ... Re-examination ("IPR") proceedings that VTech and Uniden filed ... on only certain claims of two of the patents ...
Breaking Biology Technology:
Cached News: